Table 2.
Antimicrobial resistant pattern of ESBL and Non-ESBL producing E. coli isolates
| Antimicrobial agents | Resistant isolates (%) n = 25 | ESBL (%) n = 6 | Non-ESBL (%) n = 19 | p-value* |
|---|---|---|---|---|
| Cefoperazone | 6 (30.8) | 4 (66.7) | 2 (10.5) | 0.015** |
| Cefotaxime | 5 (38.5) | 4 (66.7) | 1 (5.3) | 0.005** |
| Taxobactam/Piperacillin | 2 (15.4) | 0 | 0 | NA |
| Gentamicin | 11 (76.9) | 4 (66.7) | 7 (36.8) | 0.350 |
| Co-trimoxazole | 19 (100) | 6 (100) | 13 (68.4) | 0.278 |
| Nalidixic acid | 17 (100) | 4 (66.7) | 13 (68.4) | 1.000 |
| Norfloxacin | 15 (100) | 4 (66.7) | 11 (57.9) | 1.000 |
| Ciprofloxacin | 15 (92.3) | 4 (66.7) | 11 (57.9) | 1.000 |
| MDR | 13 (52.0) | 4 (66.7) | 9 (47.4) | 0.645 |
*
P value (from Fisher’s exact test) is the comparison of resistance of ESBL and non-ESBL producers
**
= Statistically significant (P ≤ 0.05)
NA = Not applicable